Humana Inc.

In February 2006, James E. Murray was appointed Humana’s chief operating officer. He has responsibilities for integrating all of the company’s operations and products under a single senior leader, including senior products, commercial sales and market operations, service, information technology, clinical operations and Humana Military (TRICARE). Mr. Murray was previously chief operating officer for market and business segment operations, where he focused on sales, underwriting, specialty products, network management and market management functions. Mr. Murray has held a variety of senior leadership positions since joining Humana as vice president of finance in 1989. He was promoted to vice president and chief financial officer in 1997 with responsibility for public and statutory reporting, investor relations, operating unit budget management and evaluation of acquisition opportunities. Mr. Murray is a certified public accountant and joined Humana as vice president of finance in 1989. He was promoted to vice president and chief financial officer in 1997. Before joining Humana, he served as a partner in the Louisville, Ky., office of Coopers & Lybrand (now PricewaterhouseCoopers).

James H. Bloem joined Humana in February 2001, as senior vice president and chief financial officer. In addition to supervising all accounting, actuarial, financial, tax, risk management, treasury and investor relations activities, he is responsible for helping develop business growth strategies, with a focus on industry-leading innovation in product design and the application of new technology. Previously, Mr. Bloem has served as executive vice president, then as President of the Personal Care Division of Perrigo Company, the nation's largest manufacturer of over-the-counter pharmaceuticals, personal care and nutritional products for the store brand market. Prior to that, he served as Vice President and Chief Financial Officer of Herman Miller, Inc., an international manufacturer of office furniture and furniture systems. Before that, Mr. Bloem served as Vice President and General Counsel of Herman Miller, Inc. Mr. Bloem also has worked as an independent financial and business consultant, serving national and international clients, and was a partner specializing in taxation and corporate practice in the Grand Rapids, Michigan law firm of Law, Weathers, and Richardson. Mr. Bloem holds a law degree from Vanderbilt University and a Masters of Business Administration degree from Harvard Business School. He also is a certified public accountant, and serves as a director of several corporate and educational boards.

aul B. Kusserow Senior Vice President and Chief Strategy Officer Paul Kusserow was named Senior Vice President and Chief Strategy Officer in February 2009 with responsibility for Humana’s strategic planning function as well as its merger and acquisition and venture-capital activities. Prior to joining Humana, Mr. Kusserow served as Managing Director of Private Equity at the Chicago-based investment firm B.C. Ziegler and Company. He also served as Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund, where he focused on early-stage investments in health care services and health care IT. From 2004 to 2007, he was Managing Director of San Ysidro Capital Partners LLC, a health care services consulting and investment advisory firm. A Vermont native, Paul is a Phi Beta Kappa graduate of Wesleyan University. He earned an M.A. with honors from Oxford University, where he was a Rhodes Scholar. He began his career as a consultant with McKinsey and Company.

Steven E. McCulley is Humana’s Controller and Principal Accounting Officer with responsibility for supervising all accounting, financial reporting and financial analysis functions. Mr. McCulley also oversees the establishment and maintenance of internal controls, including Sarbanes-Oxley requirements. Mr. McCulley was promoted to Vice President and Controller for the company in January 2001 after having served as Vice President and Chief Financial Officer of Market Operations. In August 2004, Humana’s Board of Directors appointed Mr. McCulley as Principal Accounting Officer. A Certified Public Accountant, Mr. McCulley previously worked at Coopers & Lybrand (now PriceWaterhouseCoopers) for 6 years before joining Humana in 1990. Mr. McCulley earned a Bachelor of Science degree in Accounting from the University of Kentucky.

Heidi Margulis, Senior Vice President, Government Relations, leads the development, execution and advocacy of Humana’s state and federal legislative initiatives. Heidi joined Humana in 1985 and has held increasingly responsible regulatory and legislative public affairs advocacy positions. She was promoted to Vice President, Government Affairs, in 1995. Two U.S. Secretaries of Health & Human Services have recognized Heidi’s expertise with appointments to Secretary Tommy Thompson's Advisory Committee on Regulatory Reform (executive committee) and Secretary Donna Shalala's Advisory Panel on Medicare Education. Heidi serves on the board of the Campaign to End Obesity, most recently served as board co-chair of Green Ribbon Health (a Medicare Health Support pilot program), chair of the Coordinating Committee of the Health & Retirement Task Force of the Business Roundtable, and serves on public policy committees of the National Business Group on Health and America's Health Insurance Plans. She has served on a variety of local, state and national civic, charitable and public-sector boards. Heidi holds a bachelor’s degree in international studies from the University of Louisville.

Dorothy Sutherland Dorothy serves as Humana Ventures Administrative Assistant. Dorothy has been with Humana since 1999 and has experience within several of Humana's strategic functions. Dorothy will be happy to arrange a meeting with the Humana Ventures team.

ROBERT SCHWARZBERG, MD., amerikanischer Staatsburger, wurde im Januar 2005 zum Mitglied der Geschaftsleitung ernannt. Dr. Schwarzberg ist ein bekannter Kardiologe und fuhrt eine eigene Privatpraxis fur Kardiologie in Boca Raton, Florida. Er wurde Medical Director von LifeWatch Holding Corp. und Mitglied des medizinischen Beirats von Card Guard in 1999. Seit 1988 betreibt er eine eigene Praxis fur Kardiologie und ist Mitglied des Verwaltungsrats und Medical Director fur eine Anzahl von Unternehmen und Institutionen wie z.B. CardioLife Corporation (Verwaltungsratsprasident und Medical Director von 1989 bis 1996), Primus Health Plan (Partner und Mitglied des Verwaltungsrats von 1995 bis 1996), Ralin Medical CorSolutions (Chief Medical Officer von 1996 bis 1999). Dr. Schwarzberg ist derzeit: Clinical Associate Professor of Biomedical Science der Florida Atlantic Universitat, der National Disease Management Working Group und Medical Director des Institute des American College of Cardiology, Mitglied der Third Party Reimbursement Group beim Florida Chapter der ACC, Verwaltungsratsmitglied der American Heart Association und Mitglied des medizinischen Beirats von Card Guard Scientific Survival Ltd. Dr. Schwarzberg ist zudem President und Chief Medical Director von Sensei Inc., einem gemeinsamen Unternehmen von Card Guard und Humana Innovation Enterprises (eine Tochtergesellschaft der Humana Inc.). Dr. Schwarzberg halt ein B.A. des Columbia College in New York und ein M.D. der Wayne State University School of Medicine in Detroit,USA. Er ist Mitglied des American College of Cardiology (F.A.C.C.).

Ty Wilburn has over 30 years of hospital industry experience, including mergers and acquisitions, finance, operations, strategic planning, and venture capital. Mr. Wilburn is responsible for maintaining the company's strategic focus and leads the management team in all initiatives. Serving as CEO since January of 2003, Mr. Wilburn has been instrumental in the company's several acquisitions. He has also taken great care in putting together a motivated and talented management team which has improved performance in all Merit owned health facilities year over year. Prior to joining Merit Health, Mr. Wilburn's experience included senior executive positions at Community Health Systems and Humana. During his career, Mr. Wilburn has led and closed more than $3 billion in transactions.

David A. Jones, Jr. was elected Chairman of the Board of the Company in April 2005, having served as Vice Chairman since September 1996. Mr. Jones is chairman and managing director of Chrysalis Ventures, LLC, a Louisville-based venture capital firm which he founded in 1993. Chrysalis Ventures provides equity capital for young growth companies in the Southeast and Midwest. Mr. Jones is immediate past chairman of the Greater Louisville Health Enterprises Network, a business consortium designed to promote the growth of the health care economy in Louisville and the surrounding region. He also serves on the advisory committee of the Brookings Center on Health Policy, on the board of the National Committee on U.S.-China Relations and on the Yale President's Council on International Activities. Prior to forming Chrysalis Ventures, Mr. Jones practiced corporate and international law. He served in the U.S. Department of State's general counsel's office from 1988 to 1992, working principally on political and economic issues involving East Asia. A magna cum laude graduate of Yale University, Mr. Jones earned a J.D. degree from the Yale University School of Law. He has been a Humana board member since 1993. He is the son of David A. Jones, the former Chairman of the Board and Humana founder, who retired effective April 2005.

Frank A. D’Amelio Frank A. D'Amelio was initially elected to the Board in September 2003. He is Chief Financial Officer of Pfizer Inc., having taken that position in September 2007. Mr. D'Amelio has almost three decades of extensive operating and financial experience at AT&T, Lucent Technologies and Alcatel-Lucent, including serving as both chief operating officer and chief financial officer at Lucent. He is also a member of the JPMorgan/Chase National Advisory Counsel.

Ashland Inc. Chairman and Chief Executive Officer James J. O'Brien, 54, knows Ashland and knows the chemical business. Since 2002, he has presided over the transformation of Ashland from a multi-industry petroleum refiner and marketer with holdings in chemicals and transportation construction into a global specialty chemicals company. O'Brien guides a company of 16,000 employees working to develop products, services and solutions that, through chemistry, meet customers' needs and contribute to improved quality of life. As chairman and chief executive officer, O'Brien leads Ashland's Executive Committee, whose members set Ashland's global strategy, manage its capital, and uphold Ashland's operating principles.

W. ROY DUNBAR , 46, has been a director of EDS since 2004. He has been President and Chief Executive Officer of Network Solutions, a provider of Web related services, since February 2008. Mr. Dunbar was President Global Technology and Operations of Master Card International from September 2004 to January 2008, and president, intercontinental operations of Eli Lilly and Company, responsible for its Asia, Africa/Middle East, Latin America and the Confederation of Independent States operations from January 2004 to September 2004. He had served as vice president of information technology and chief information officer of Eli Lilly since 1999 and joined Eli Lilly in 1990. Mr. Dunbar is also a director of Humana Inc.

William E. Mitchell, 65, is Chairman, a Director, Chief Executive Officer and the former President of Arrow Electronics, Inc., and Director with Brown-Forman Corporation. Mr. Mitchell previously served on the Rogers Board of Directors from 1994 to the April 26, 2007 Annual Meeting of Shareholders when he chose not to stand for re-election becuase of other business commitments. However, Mr. Mitchell was asked to rejoin the Rogers Board in 2008 and was elected at the May 9, 2008 Annual Meeting of Shareholders.